Ionis Pharmaceuticals (NASDAQ:IONS) prices $500M aggregate principal amount of 1.75% convertible senior notes due 2028 in a private placement to qualified institutional buyers. The initial purchasers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback